Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) FCF Margin: 2010-2012

Historic FCF Margin for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -32.88%.

  • Sonoma Pharmaceuticals' FCF Margin rose 1106.00% to -32.88% in Q4 2012 from the same period last year, while for Dec 2012 it was 3.19%, marking a year-over-year increase of 2774.00%. This contributed to the annual value of -34.27% for FY2012, which is 1292.00% up from last year.
  • As of Q4 2012, Sonoma Pharmaceuticals' FCF Margin stood at -32.88%, which was down 133.10% from 99.34% recorded in Q3 2012.
  • In the past 5 years, Sonoma Pharmaceuticals' FCF Margin ranged from a high of 99.34% in Q3 2012 and a low of -71.03% during Q4 2010.
  • Over the past 3 years, Sonoma Pharmaceuticals' median FCF Margin value was -32.88% (recorded in 2012), while the average stood at -27.12%.
  • The largest annual percentage gain for Sonoma Pharmaceuticals' FCF Margin in the last 5 years was 12,606bps (2012), contrasted with its biggest fall of 4,046bps (2012).
  • Over the past 3 years, Sonoma Pharmaceuticals' FCF Margin (Quarterly) stood at -71.03% in 2010, then soared by 2,709bps to -43.94% in 2011, then spiked by 1,106bps to -32.88% in 2012.
  • Its FCF Margin stands at -32.88% for Q4 2012, versus 99.34% for Q3 2012 and -31.25% for Q2 2012.